Basics Amneal Pharmaceuticals, Inc. IPO Date: January 1, 1900 Sector: Healthcare Industry: Biotech Market Cap: $3.02B Activated in VL: True Average Daily Range Avg Daily Range: $0.15 | 2.49% Avg Daily Range (30 D): $0.12 | 1.42% Avg Daily Range (90 D): $0.12 | 1.47% Institutional Daily Volume Avg Daily Volume: .39M Avg Daily Volume (30 D): 1.31M Avg Daily Volume (90 D): 1.34M Trade Size Avg Trade Size (Sh.): 150 Avg Trade Size (Sh.) (30 D): 102 Avg Trade Size (Sh.) (90 D): 101 Institutional Trades Total Inst.Trades: 1,711 Avg Inst. Trade: $1.56M Avg Inst. Trade (30 D): $1.9M Avg Inst. Trade (90 D): $2.02M Avg Inst. Trade Volume: .19M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.69M Avg Closing Trade (30 D): $2.06M Avg Closing Trade (90 D): $2.26M Avg Closing Volume: 204.39K     News Aug 27, 2025 @ 12:00 PM Binge Eating Disorders Global Market Research Repo... Source: Researchandmarkets.Com Jul 18, 2025 @ 11:00 AM Knight Therapeutics Announces Filing of New Drug S... Source: Knight Therapeutics Inc. Jul 18, 2025 @ 11:00 AM Thérapeutique Knight annonce le dépôt dâ... Source: Samira Sakhia Jun 25, 2025 @ 12:00 PM Amneal Highlights Positive Topline Results from Co... Source: N/A Jun 12, 2025 @ 12:00 PM Amneal Receives U.S. FDA Approval for Prednisolone... Source: Amneal Pharmaceuticals, Inc. Financials   TTM Q1 2025 Q4 2024 Basic EPS $.07 $.04 $-.1 Diluted EPS $.07 $.04 $-.1 Revenue $ 724.51M $ 695.42M $ 730.52M Gross Profit $ 286.25M $ 255.89M $ 262.87M Net Income / Loss $ 35.61M $ 24.62M $ -20.74M Operating Income / Loss $ 111.37M $ 100.35M $ 75.79M Cost of Revenue $ 438.26M $ 439.53M $ 467.65M Net Cash Flow $ 15.28M $ -50.03M $ 40.08M PE Ratio 135.71     Splits Aug 26, 2013:   1:25